Investment area

Venture Investments


North America

Date of investment

May 2023

Octave is a modern behavioral health practice creating a new standard for care delivery that’s both high-quality and accessible to more people. With in-person and virtual clinics, the company offers personalized care plans that can include individual, couples, and family therapy, while pioneering relationships with payers to make care more affordable through insurance. Grounded in science, Octave enables clients to experience profound change that is as measurable as it is meaningful.

Visit site


Eric M. Snyder


Departments: Venture Investments, Novo Ventures US Inc.

Eric joined Venture Investments (US) Inc. in March, 2018.

Previously, Eric was a managing director for Navigant Consulting, a strategic consulting firm supporting life science companies and investors, based in New York. Before joining Navigant, he worked as a management consultant for McKinsey and Leerink Partners Consulting, as well as in the global market analytics team at Pfizer with a focus on business development.

Eric earned a PhD in Neuroscience from Brown University and conducted post-doctoral studies at the Fisher Center for Alzheimer’s Disease at Rockefeller University.